Trade Mark Journal No.2026/002 9 January 2026
WO0000001890785 (5)
Office of origin: United States of America
Date of International Registration:18 November 2025
Date of designation in the UK:
18 November 2025

International priority date claimed: 20 May 2025
(United States of America)
(99194426)
- Class 5
- Pharmaceutical preparations, namely, antivirals.
Atea Pharmaceuticals, Inc.
Representative: Kilpatrick Townsend & Stockton LLP, 1100 Peachtree Street, , Suite 2800, Atlanta GA 30309, UNITED STATES OF AMERICA